top of page
LOGO_GeneSuites_white.png
Pipetting Samples

We are an experienced real estate team led by GMP expertise.

GeneSuites is a development and strategic partner that removes barriers for life science companies beginning phase II-III clinical trials or seeking to enter the U.S. market. In partnership with industry experts and validated by third-party reviewers, GeneSuites was founded in 2020 with a novel solution to address the imbalance in supply and demand for biomanufacturing capacity while offering critical PD and cGMP manufacturing advantages. 

We specialize in advancing biomanufacturing strategies from beginning to end.

  • Site Procurement

  • Financing

  • Development & Construction

  • Operational Expertise

Experience
Building & Operating
cGMP Facilities

data-scientist-wh.png

CDMO/CMO &
Life Science
User Perspective

network-wh.png

Industry Relationships

cGMP, Lab, Construction, 
Real Estate, Capital Partners

prototype-wh.png

Real Estate Strategies
& Development

marketknowledge-wh.png

Market
Knowledge

TeamAnchor

Meet Our Team

SScott_Headshot_update-bw.png

Steve Scott
Managing Partner

DLozier_Headshot_bw.jpg

Doug Lozier
Chief Investment Officer

2022_Gary_0016x.jpg

Gary Schoenhouse, P.E.
Chief Technical Officer

MCaldwell_bw2.jpg

Maclain Caldwell
Chief Financial Officer

JeannieMa_edited_edited.jpg

Jeannie Ma
Director, Marketing & Communications

Our team has worked  in partnership with some of the top life science and partner companies

LOGO_Genentech-wh.png
LOGO_Roche-wh.png
LOGO_Resilience-wh.png
LOGO_OrchardTherapeutics-wh.png
LOGO_Biogen-wh.png
LOGO_Novartis-wh.png
LOGO_BDBiosciences-wh.png
LOGO_BASF-wh.png
LOGO_Alere-wh.png
LOGO_Monsanto-wh.png
LOGO_Paxvax-wh.png
LOGO_Neomorph_HR-wh.png
bottom of page